Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

ClinicalTrials.gov ID: NCT01650805

Public ClinicalTrials.gov record NCT01650805. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 12:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized,Open-Label Study of Ponatinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the efficacy of ponatinib and imatinib in patients with newly diagnosed chronic myeloid leukemia (CML) in the chronic phase.

Study identification

NCT ID
NCT01650805
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ariad Pharmaceuticals
Industry
Enrollment
307 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2012 (Type not available)
Primary completion
Oct 2013 (Actual)
Completion
Oct 2013 (Actual)
Last update posted
Nov 17, 2014

2012 – 2013

United States locations

U.S. sites
67
U.S. states
34
U.S. cities
56
Facility City State ZIP Site status
US Oncology - Providence Health System, Site #167 Burbank California 91505 —
UCLA Department of Medicine, Site #027 Los Angeles California 90095 —
Bay Area Cancer Research Group, Site #156 Pleasant Hill California 94523 —
Bay Area Cancer Research Group, Site #157 Pleasant Hill California 94523 —
Rocky Mountain Cancer Centers, Site #191 Boulder Colorado 80303 —
Cancer Center of Central Connecticut, Site #147 Southington Connecticut 06489 —
Christiana Care Health Services, Site #155 Newark Delaware 19713 —
University Cancer Institute, Site #149 Boynton Beach Florida 33426 —
Florida Cancer Specialists, Site #180 Fort Meyers Florida 33916 —
Florida Cancer Specialists, Site #179 St. Petersburg Florida 33705 —
Emory University, Site #058 Atlanta Georgia 30322 —
John H. Stroger, Jr. Hospital of Cook County, Site #192 Chicago Illinois 60612 —
University of Chicago, Site #001 Chicago Illinois 60637 —
Loyola University Chicago, Site #054 Maywood Illinois 60153 —
Franciscan St. Francis Health, Site #138 Indianapolis Indiana 46237 —
University of Iowa Hospitals and Clinics, Site #050 Iowa City Iowa 52242 —
Siouxland Hematology-Oncology Associates, Site #198 Sioux City Iowa 51101 —
US Oncology - Cancer Center of Kansas, Site #168 Wichita Kansas 67214 —
Willis-Knighton Cancer Center, Site #196 Shreveport Louisiana 71103 —
University of Maryland, Greenebaum Cancer Center, Site #040 Baltimore Maryland 21201 —
Greater Baltimore Medical Center, Site #140 Baltimore Maryland 21204 —
St. Agnes Healthcare, Site #185 Baltimore Maryland 21229 —
Massachusetts General Hospital, Site #047 Boston Massachusetts 02114 —
Dana Farber Cancer Institute, Site #008 Boston Massachusetts 02215 —
University of Massachusetts Worcester, Site #152 Worcester Massachusetts 01655 —
University of Michigan Medical Center, Site #011 Ann Arbor Michigan 48109 —
Providence Cancer Institute, Site #197 Southfield Michigan 48075 —
Mayo Clinic, Site #044 Rochester Minnesota 55905 —
Oncology Research Park Nicollet Institute, Site #195 Saint Louis Park Minnesota 55426 —
Saint Luke's Hospital, Site #162 Kansas City Missouri 64111 —
Mercy Clinic - Cancer & Hematology, Site #151 Springfield Missouri 65804 —
Nebraska Hematology-Oncology, P.C., Site # 133 Lincoln Nebraska 68506 —
US Oncology - Comprehensive Cancer Center of Nevada, Site #169 Las Vegas Nevada 89169 —
John Theurer Cancer Center, Site #128 Hackensack New Jersey 07601 —
University of New Mexico Cancer Center, Site #166 Albuquerque New Mexico 87106 —
Maimonides Cancer Center, Site #177 Brooklyn New York 11220 —
Winthrop University Hospital, Site #153 Mineola New York 11501 —
Beth Israel Medical Center, Site #145 New York New York 10003 —
Mount Sinai School of Medicine, Site #189 New York New York 10029 —
Memorial Sloan-Kettering Cancer Center, Site #078 New York New York 10065 —
Weill Cornell Medical College, Site #006 New York New York 10065 —
New York Medical College, Site #146 Valhalla New York 10595 —
Southeastern Medical Oncology Center, Site #188 Goldsboro North Carolina 27534 —
Signal Point Clinical Research Center, Site #139 Middletown Ohio 45042 —
University of Oklahoma, Site #028 Oklahoma City Oklahoma 73104 —
Providence Cancer Center Oncology and Hematology Care Eastside, Site #194 Portland Oregon 97213 —
Kaiser Permanente Northwest, Site #200 Portland Oregon 97227 —
Oregon Health & Science University, Site #048 Portland Oregon 97239 —
Gettysburg Cancer Center, Site #160 Gettysburg Pennsylvania 17325 —
Western Pennsylvania Hospital, Site #159 Pittsburgh Pennsylvania 15224 —
Medical University of South Carolina, Site #148 Charleston South Carolina 29425 —
Carolina Hematology Oncology, Site #143 Sumter South Carolina 29150 —
Associates in Oncology & Hematology, Site #186 Chattanooga Tennessee 37421 —
Sarah Cannon Research Institute, Site #076 Nashville Tennessee 37203 —
US Oncology - Texas Oncology Austin, Site #172 Austin Texas 78705 —
US Oncology - Texas Oncology Dallas, Site #171 Dallas Texas 75231 —
University of Texas Southwestern Medical Center, Site #178 Dallas Texas 75390 —
Baylor College of Medicine, Site #063 Houston Texas 77030 —
US Oncology - Texas Oncology Midland, Site #173 Midland Texas 79701 —
US Oncology - Cancer Care Center of South Texas, Site #170 San Antonio Texas 78229 —
Huntsman Cancer Institute, Site #043 Salt Lake City Utah 84112 —
VCU Massey Cancer Center, Dalton Oncology Clinic, Site #069 Richmond Virginia 23298 —
Seattle Cancer Care Alliance, Site #100 Seattle Washington 98109 —
US Oncology - Northwest Cancer Specialists, Site #174 Vancouver Washington 98684 —
West Virginia University, Site #154 Morgantown West Virginia 26506 —
Green Bay Oncology, Ltd. / St. Mary's Hospital Medical Center, Site #193 Green Bay Wisconsin 54303 —
University of Wisconsin, Site #030 Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 103 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01650805, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2014 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01650805 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →